|1.||Ganslmayer, Marion: 3 articles (05/2005 - 12/2002)|
|2.||Schuppan, Detlef: 3 articles (05/2005 - 12/2002)|
|3.||Ocker, Matthias: 3 articles (05/2005 - 12/2002)|
|4.||Hahn, Eckhart G: 3 articles (05/2005 - 12/2002)|
|5.||Nahar, Lutfun: 2 articles (09/2012 - 07/2010)|
|6.||Heidecke, Claus-Dieter: 2 articles (03/2007 - 08/2004)|
|7.||Stadler, Josef: 2 articles (03/2007 - 08/2004)|
|8.||Westerholt, Alexandra: 2 articles (03/2007 - 08/2004)|
|9.||Maier, Stefan: 2 articles (03/2007 - 08/2004)|
|10.||Giannini, E: 2 articles (08/2006 - 01/2000)|
|1.||Liver Diseases (Liver Disease)
12/01/1976 - "Aminopyrine disposition: studies on breath, saliva, and urine of normal subjects and patients with liver disease."
03/01/1993 - "Patients were divided into two groups according to the severity of their liver disease using Child's classification and the aminopyrine breath test (AB test). "
01/01/1993 - "The contribution of the aminopyrine-breath-test in metastatic liver disease."
01/01/1991 - "Patients with severe chronic liver diseases had lower results of aminopyrine breath test, if they drink alcohol regular. "
01/01/1991 - "Patients with chronic liver diseases of fewer severity had higher mean values of aminopyrine breath test, if they had chronic alcohol consumption. "
03/01/1990 - "A Pugh score (combining five variables) superior to 8 or a p value inferior to 0.7 of a logistic regression equation containing only two variables (score of ascites and result of 14C aminopyrine breath test) were found to be highly effective for making this decision."
06/01/1992 - "Survival was univariately related to aminopyrine breath test (p less than 0.02), Pugh score (p less than 0.01), presence of ascites (p less than 0.01), and sex (p less than 0.05). "
01/01/1992 - "The best prognostic index was obtained with two independent variables: ascites and aminopyrine breath test. "
01/01/1990 - "Of 19 variables that entered into the analysis, only two were significant (P less than 0.01): presence (1: moderate; 2: severe) or absence (0) of ascites (A) and breath test (BT: % aminopyrine activity of administered dose at 2 hr). "
03/01/1997 - "We compared the utility of two exogenous tests (aminopyrine breath test and lidocaine metabolization test), two clinical parameters (encephalopathy, ascites), 18 endogenous tests and five scores (Pugh, Merkel, Orrego, Adler, Pignon) for predicting 1-year mortality in patients with parenchymal cirrhosis. "
06/01/1998 - "In the present study, we aimed at evaluating whether serial determinations of aminopyrine breath test and Child-Pugh score improve prognostic accuracy in patients with cirrhosis, compared with determinations obtained only on admission. "
01/01/2003 - "In cirrhosis, dose/h correlated (r=0.68) to aminopyrine breath test values, a microsomal function test, and was inversely correlated (r=-0.48) to the Child-Pugh score. "
06/01/1998 - "These data suggest that serial determinations of Child-Pugh score and aminopyrine breath test can be used to efficiently update prognosis of cirrhosis."
06/01/1998 - "Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates."
02/01/1995 - "To assess the value of aminopyrine breath test as an adjunct to Child-Turcotte-Pugh score in prognostic evaluation of patients with cirrhosis, two approaches have been used: a regression analysis using Cox's proportional hazard model by including the Child-Turcotte-Pugh score and aminopyrine breath test value, and the log-rank test to assess the prognostic value of aminopyrine breath test in each Child-Turcotte-Pugh class separately. "
|4.||Liver Cirrhosis (Hepatic Cirrhosis)
06/01/1998 - "In 74 patients with liver cirrhosis aminopyrine breath test and Child-Pugh score were obtained upon entry into the study. "
01/01/1991 - "[Studies on diagnostic and prognostic validity of aminophenazone breath test in liver cirrhosis]."
01/01/1991 - "In 59 patients with liver cirrhosis (23 female, 36 male; aged between 30 and 73 years) the aminophenazone breath-test according to the Haustein-Schenker modification was performed. "
10/01/1987 - "Aminopyrine N-demethylation by rats with liver cirrhosis. "
11/30/1985 - "[Relation between serum biliary acid and respiratory test with 14C aminopyrine in patients with hepatic cirrhosis]."
05/18/1951 - "[Intravenous aminophenazone therapy in inflammation of the gallbladder and biliary tract]."
12/01/2005 - "Five groups were included in each of the acute and subacute inflammation studies: the vehicle control group, positive control group (aminopyrine 100 mg/kg), pinitol group (20 mg/kg), glucosamine group (25 mg/kg) and a pinitol (20 mg/kg) and glucosamine (25 mg/kg) combination group. "
01/01/1958 - "[Studies on antiphlogistic effect of aminopyrine, phenylbutazone and sodium salicylate on experimentally induced inflammations in splenectomized rats]."
01/01/2008 - "Thus, the scavenging effect observed for dipyrone and aminopyrine will almost certainly contribute to their healing effect in the treatment of prolonged or chronic inflammation, while that of the other studied NSAIDs may have a lower contribution, though these assumptions still require further in vivo validation."
03/01/1989 - "Cu(II) complexes with salicylates or aminopyrine were administered to rats with local inflammation (acute paw oedema elicited with carrageenan) to determine their anti-inflammatory activity and ulcerogenic effects following oral administration. "
|5.||Technetium Tc 99m Diethyl-iminodiacetic Acid
|7.||Glycochenodeoxycholic Acid (Glycochenodeoxycholate)
|8.||Aspirin (Acetylsalicylic Acid)
|9.||Indocyanine Green (Cardio-Green)
|5.||Drug Therapy (Chemotherapy)